Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review

Most conventional insomnia medications are gamma‐aminobutylic acid receptor agonists. However, physical dependence is a concern and one of the major limiting factors for long‐term treatment. The dual orexin receptor antagonists, suvorexant and lemborexant, were recently approved for treating chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Nishida, Maika, Koebis, Michinori, Taninaga, Takehiro, Muramoto, Kenzo, Kubota, Naoki, Moline, Margaret, Sakuma, Kenji, Okuya, Makoto, Nomura, Ikuo, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698673/
https://www.ncbi.nlm.nih.gov/pubmed/34553844
http://dx.doi.org/10.1002/npr2.12205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698673/
https://www.ncbi.nlm.nih.gov/pubmed/34553844
http://dx.doi.org/10.1002/npr2.12205

Ejemplares similares